Want to see AU:EBR full AI Analyst Report?
EBR Stock Chart & Stats
AU$0.30
-AU$0.06(-18.33%)
At close: 4:00 PM EDT
AU$0.30
-AU$0.06(-18.33%)
Day’s Range― - ―
52-Week RangeAU$0.24 - AU$1.38
Previous CloseN/A
Volume17.49M
Average Volume (3M)694.25K
Market Cap
AU$229.76M
Enterprise ValueAU$154.11
Total Cash (Recent Filing)AU$85.90M
Total Debt (Recent Filing)AU$59.65M
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding753,305,600
10 Day Avg. Volume604,410
30 Day Avg. Volume694,249
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)9.73
Price to Sales (P/S)148.94
P/FCF Ratio-4.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.49Price Target Upside395.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.33
Revenue Forecast (FY)AU$14.67M
Bulls Say, Bears Say
Bulls Say
Commercial Adoption Is AcceleratingRapid revenue expansion, increasing implant volumes, hospital contracts and physician training indicate that WiSE is progressing from limited launch toward repeatable commercial adoption in cardiac resynchronization therapy.
CMS Reimbursement Pathway Improves Market AccessA formal Medicare coverage review could establish a consistent reimbursement framework for eligible patients. A favorable decision would reduce hospital adoption barriers and support broader utilization of WiSE across the U.S. market.
Capital Base Has StrengthenedHigher equity and lower relative leverage improve financial resilience compared with the prior annual period. This provides greater capacity to fund manufacturing, commercial expansion and research while the business works toward scale.
Bears Say
Heavy Cash Burn Creates Funding DependenceThe company is not yet self-funding: operating and free cash flow remain deeply negative despite revenue growth. Continued spending on commercialization and development may require further external capital before revenue reaches breakeven.
Profitability Remains Far From BreakevenRevenue traction has not yet translated into operating leverage. Modest gross margins and substantial losses relative to sales indicate that manufacturing, sales and development costs must improve materially for growth to become durable earnings.
Device Safety Events Remain A Regulatory RiskAlthough management classified the events as isolated and linked to a known imaging hazard, a death and continuing regulatory review could increase monitoring, training and adoption requirements, potentially slowing expansion or raising compliance costs.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh News
EBR FAQ
What was EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price range in the past 12 months?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh lowest share price was AU$0.24 and its highest was AU$1.38 in the past 12 months.
What is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap is AU$229.76M.
When is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date is Mar 03, 2027 which is in 187 days.
How were EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s earnings last quarter?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh released its earnings results on Jul 30, 2026. The company reported -AU$0.496 earnings per share for the quarter, missing the consensus estimate of -AU$0.048 by -AU$0.448.
Is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh overvalued?
According to Wall Street analysts EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price is currently Undervalued.
Does EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh pay dividends?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh does not currently pay dividends.
What is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh have?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 753,305,600 shares outstanding.
What happened to EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price movement after its last earnings report?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh reported an EPS of -AU$0.496 in its last earnings report, missing expectations of -AU$0.048. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh?
Currently, no hedge funds are holding shares in AU:EBR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$1.49 (395.56% Upside)
AU$1.49 (395.56% Upside)
Blogger Sentiment
Bullish
AU:EBR Sentiment 97%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$29.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
14.14%
Trailing 12-Months
Company Description
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart. This innovative approach helps overcome the typical challenges linked to traditional pacing leads, including complex insertion, inadvertent nerve activation, displacement, removal procedures, and subsequent adjustments. Established in 2003, the company operates out of Sunnyvale, California.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR) Earnings & Revenues
EBR Stock 12 Month Forecast
Average Price Target
AU$1.49
▲(395.56% Upside)
Technical Analysis
Cochlear
―
Impedimed Limited
―
Uscom Limited
―
Micro-X Ltd.
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―




